Manufacturer record
Hanuchem Laboratories: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Hanuchem Laboratories (Himachal Pradesh) were declared Not of Standard Quality between March 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
7 records linked to Hanuchem Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Fluorometholone Eye Drops IP , Flomia Eyedrops | HE5106AMfg 2025-04 · Exp 2027-03 | The sample does not conform to IP standards. This particular batch of sample fails the tests Sterility and AssayAssay | RDTL, ErnakulamState lab | Jun 2026 |
| Calcium and Vitamin D3 Tablets IP | HCL5154Mfg 2025-04 · Exp 2027-03 | Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab | Apr 2026 |
| Calcium and Vitamin D3 Tablets IP (GENIBONE- 500) | HCL5011Mfg 2025-01 · Exp 2026-12 | DescriptionDescription | State Lab KarnatakaState lab | Jun 2025 |
| Calcium and Vitamin D3 Tablets IP (MAHACAL -500) | KSWAC014Mfg 2023-05 · Exp 2025-04 | Assay of Vitamin D3Assay | CDL KolkataCDSCO lab | Feb 2024 |
| TELMISARTAN TABLETS IP 20 MG (TELTAN 20) | HCL2317Mfg 2022-11 · Exp 2024-10 | Test for DissolutionDissolution | CDTL HyderabadCDSCO lab | Jun 2023 |
| Azithromycin Oral Suspensions I.P. 100 mg | L-1724703Mfg 2017-11 · Exp 2019-10 | Assay & pHAssay | RDTL GuwahatiState lab | Oct 2019 |
| Moxifloxacin with Difluprednate Eye Drops ( MOXITAK- DF STERILE EYE DROPS) | PE085Mfg 2017-05 · Exp 2019-04 | Assay of DifluprednateAssay | RDTL ChandigarhState lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.